Day

March 26, 2020

26
Mar
2020

Adjusting to Telemedicine: A First-Hand Account

One consequence of the present crisis is the urgent embrace of telemedicine, as I recently discussed. Whether the adoption is sustained beyond the crisis period remains to be determined, although use seemed to be increasing overall even before the pandemic hit.  As more physicians and patients find themselves pressed to adopt telemedicine, I thought it might be helpful to better...
Read More
26
Mar
2020

Pharmacy as the Biomarker of Biopharma’s Strategic Change, After Coronavirus

Maybe it was my jarring transition from a decade and a half inside the gilded halls of large pharma to the rough-and-tumble world of retail pharmacy 10 years ago, but I’m a wee bit cautious of the current self-congratulatory tone of the biopharma industry’s response to the pandemic.  I’ll certainly be delighted if Regeneron and Sanofi’s IL-6 receptor inhibitor sarilumab...
Read More